TP53 and non-small cell lung carcinoma: A number of Set7/9 non-histone substrates, including p53 (33), MDM2 (34), E2F1 (16), STAT3 (21), affect proliferation, apoptosis, and resistance of NSCLC cells against chemotherapeutics.